Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Sachiko Yoshimura"'
Autor:
Shinji Morisaki, Hideya Onishi, Takafumi Morisaki, Makoto Kubo, Masayo Umebayashi, Hiroto Tanaka, Norihiro Koya, Shinichiro Nakagawa, Kenta Tsujimura, Sachiko Yoshimura, Poh Yin Yew, Kazuma Kiyotani, Yusuke Nakamura, Masafumi Nakamura, Takanari Kitazono, Takashi Morisaki
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Neoantigens/ are tumor-specific antigens that evade central immune tolerance mechanisms in the thymus. Long-term tumor-specific cytotoxic T lymphocyte activity maintenance requires class II antigen-reactive CD4+ T cells. We had previously shown that
Externí odkaz:
https://doaj.org/article/8a24b0348b3c46f88fc706dfa5b638e0
Autor:
Takafumi Morisaki, Makoto Kubo, Masayo Umebayashi, Poh Yin Yew, Sachiko Yoshimura, Jae-Hyun Park, Kazuma Kiyotani, Masaya Kai, Mai Yamada, Yoshinao Oda, Yusuke Nakamura, Takashi Morisaki, Masafumi Nakamura
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Neoantigens are tumour-specific antigens that arise from non-synonymous mutations in tumour cells. However, their effect on immune responses in the tumour microenvironment remains unclear in breast cancer. We performed whole exome and RNA se
Externí odkaz:
https://doaj.org/article/2c8160b2daa6447d8caac1e64206aa46
Autor:
Miki Tsuruta, Shohei Ueda, Poh Yin Yew, Isao Fukuda, Sachiko Yoshimura, Hiroyuki Kishi, Hiroshi Hamana, Masatoshi Hirayama, Junji Yatsuda, Atsushi Irie, Satoru Senju, Eiji Yuba, Tomomi Kamba, Masatoshi Eto, Hideki Nakayama, Yasuharu Nishimura
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
DEP domain containing 1 (DEPDC1) and M-phase phosphoprotein 1 (MPHOSPH1) are human cancer testis antigens that are frequently overexpressed in urinary bladder cancer. In a phase I/II clinical trial, a DEPDC1- and MPHOSPH1-derived short peptide vaccin
Externí odkaz:
https://doaj.org/article/a381e4ac4ae24f4b8b66f97b7ddc00da
Autor:
Sachiko Yoshimura, Takuya Tsunoda, Ryuji Osawa, Makiko Harada, Tomohisa Watanabe, Tetsuro Hikichi, Masahiro Katsuda, Motoki Miyazawa, Masaji Tani, Makoto Iwahashi, Kazuyoshi Takeda, Toyomasa Katagiri, Yusuke Nakamura, Hiroki Yamaue
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85267 (2014)
We herein report the identification of an HLA-A2 supertype-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2), which is known to be a diagnostic marker and a potential therapeutic target for renal cell carcinoma. Among several
Externí odkaz:
https://doaj.org/article/28c7bb87892c48b98b542abcfdb423e9
Autor:
Masayo Umebayashi, Muneyuki Masuda, Norihiro Koya, Yusuke Nakamura, Masafumi Nakamura, Poh Yin Yew, Hiroto Tanaka, Shu Ichimiya, Hideya Onishi, Shinichiro Nakagawa, Takashi Morisaki, Ryuji Yasumatsu, Akiko Fujimura, Sachiko Yoshimura, Shogo Masuda
Publikováno v:
Immunological Investigations. 51:1498-1514
Although immune checkpoint inhibitors (ICIs) have emerged as new therapeutic options for refractory cancer, they are only effective in select patients. Tumor antigen-pulsed dendritic cell (DC) vaccine therapy activates tumor-specific cytotoxic T lymp
Autor:
Jae-Hyun Park, Sachiko Yoshimura, Mai Yamada, Masafumi Nakamura, Masayo Umebayashi, Poh Yin Yew, Takafumi Morisaki, Makoto Kubo, Yoshinao Oda, Takashi Morisaki, Yusuke Nakamura, Kazuma Kiyotani, Masaya Kai
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports
Scientific Reports
Neoantigens are tumor-specific antigens that arise from non-synonymous mutations in tumor cells. However, their effect on the immune responses in tumor microenvironment are still unclear in breast cancer.We performed whole exome and RNA sequencing of
Autor:
Tetsuro Hikichi, Junji Kishimoto, Yoichi Nakanishi, Kazunari Yamada, Hisanobu Ogata, Kenzaburo Tani, Toshihisa Tsuruta, Mutsunori Murahashi, Sachiko Yoshimura, Yasuki Hijikata
Publikováno v:
Anticancer Research. 41:1485-1496
Background As the prognosis of biliary tract cancer (BTC) is extremely poor and treatment options are limited, new treatment modalities are urgently needed. We designed a phase II clinical trial to investigate the immune responses and clinical benefi
Autor:
Sachiko Yoshimura, Takafumi Morisaki, Tetsuro Hikichi, Takashi Morisaki, Makoto Kubo, Yusuke Nakamura, Tatsuya Hirano, Kazuma Kiyotani, Hideya Onishi
Publikováno v:
Immunological Investigations. 50:562-579
Chemorefractory ovarian cancer has limited therapeutic options. Hence, new types of treatment including neoantigen-specific immunotherapy need to be investigated. Neoantigens represent promising targets for personalized cancer immunotherapy. We here
Autor:
Makoto Kubo, Ario Takeuchi, Keisuke Monji, Hiroto Tanaka, Yusuke Nakamura, Takafumi Morisaki, Masayo Umebayashi, Kenta Tsujimura, Takashi Morisaki, Shinji Morisaki, Masatoshi Eto, Poh Yin Yew, Hideya Onishi, Norihiro Koya, Sachiko Yoshimura, Tatsuya Hirano, Kazuma Kiyotani, Shinichiro Nakagawa
Publikováno v:
Anticancer research. 41(8)
Background/aim Neoantigens are tumor-specific antigens that emerge due to gene mutations in tumor cells, and are highly antigenic epitopes that escape central immune tolerance in the thymus, making cancer vaccine therapy a desirable option. Patients
Autor:
Sachiko Yoshimura
Publikováno v:
United Nations Financial Sanctions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14194f94c5771ee54731dcb5e90c8184
https://doi.org/10.4324/9780429260315-1
https://doi.org/10.4324/9780429260315-1